In this week’s issue:
- American Association for Cancer Research – Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research
- Burroughs Wellcome Fund – Underrepresented Minority Enrichment Program
- American Pain Society – The Rita Allen Foundation and the American Pain Society 2013 Award in Pain
- UBC Faculty of Medicine – The Margolese National Brain and Heart Disorders Prizes
- AllerGen Emerging Clinician-Scientist Research Fellowship 2013 – Request for Applications
Awards and Honours
- 2012 SCRIPT Award
- Café Scientifique: Paralympic wheelchair athletes: struggles behind the gold
Deadline: November 20, 2012
The Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research was established to recognize the outstanding achievement of a junior faculty-level scientist working in the field of cancer prevention, and support his or her novel and innovative research that, if successful, will have strong potential for high impact in the cancer prevention field. Proposed projects may differ from current accepted practice and break new ground or extend previous findings in new directions and therefore, may not be supported by substantial preliminary data. Accordingly, such projects will be evaluated based on the conceptual framework, the level of innovation, and the potential for high reward. Applications will be accepted from academic, medical, or research institutions anywhere in the world.
The grant provides $100,000 over two years ($50,000 per year) for direct research expenses. It is anticipated that one grant will be funded.
Deadline: January 15, 2013
The URM Postdoctoral Enrichment Program award provides a total of $50,000 over three years to support the development of a URM postdoctoral fellow in a degree-granting institution (or its affiliated graduate and medical schools, hospitals and research institutions) in the United States or Canada. Individual URM postdoctoral fellows conducting biomedical or medical research are eligible to apply.
Deadline: January 17, 2013
The Rita Allen Foundation (RAF) and American Pain Society (APS) announce the 2013 Award in Pain. The RAF and APS may award two grants in the amount of $50,000 annually, for a period of up to three years to those research proposals demonstrating the greatest merit and potential for success. Proposed research projects should be directed towards the molecular biology of pain and/or basic science topics related to the development of new analgesics for the management of pain due to terminal illness.
Deadline: February 15, 2013, 11:59 pm, PST
The Margolese National Brain and Heart Disorders Prizes establishes two prizes, one each for Brain Disorders and Heart Disorders. The Margolese National Brain Disorders Prize will be awarded annually to a Canadian citizen who has made outstanding contributions to the treatment, amelioration, or cure of brain disorders. The Margolese National Heart Disorders Prize will be awarded annually to a Canadian citizen who has made outstanding contributions to the treatment, amelioration, or cure of heart disorders. The Prizes are awarded with the expectation that the Prize recipients will continue to demonstrate excellence in their field of work.
Monetary Award for each Prize:
Two prizes of $50,000 payable in Canadian dollars will be awarded annually, one in each of the two categories. The value of the Prizes will be reevaluated every third year.
For more information please visit the website.
Deadline: April 12, 2013
The goal of the AllerGen Emerging Clinician-Scientist Research Fellowship is to enable Canadian Allergists and Clinical Immunologists to pursue allergy, asthma and/or anaphylaxis academic research training immediately following their Clinical Immunology and Allergy sub-specialty training.
The quality of the research or training opportunity and the potential for a combined career as a clinician and researcher are the principal criteria on which applications will be judged.
Eligible academic foci include basic and/or clinical research related to allergy, asthma and/or anaphylaxis.
Value of the Award:
The AllerGen Emerging Clinician-Scientist Research Fellowship provides a stipend of up to $250,000 for a maximum of two years for clinicians who have completed Clinical Immunology and Allergy sub-specialty training at a Canadian academic health sciences centre. Preference will be given to applicants whose host institution can confirm that the applicant has been identified for a junior faculty position following successful completion of the Fellowship and/or continued provincial research funding support.
AllerGen encourages applicants to secure matching funding to a level commensurate with their level of clinical training.
Duration of Support:
The duration of support provided to successful applicants will be for two years. A $100,000 Fellowship plus a $25,000 research allowance will be awarded in each of the two years of this Fellowship. Awardees will be eligible to receive year-two funds subject to AllerGen’s satisfactory evaluation of a written report demonstrating progress. This Award is non-renewable.
AWARDS AND HONOURS
Deadline: December 21, 2012 5:00 PM E.T.
The SCRIPT Award, launched in 2008, celebrates excellence in writing by science graduates. Entrants to the SCRIPT Award compete for the $1000 top prize by submitting an epic story of exactly 100 words on any subject.
For more information please see the attached poster and click on the link above.
Date: November 19, 2012 7-9 pm
Location: Blusson Spinal Cord Centre Atrium
Join ICORD researchers Dr. Andrei Krassioukov, Dr. Chris West, and Dr. Jaimie Borisoff for Café Scientifique on November 19th, from 7-9pm in the Blusson Spinal Cord Centre Atrium.
Join us for refreshments and lively discussion about the challenges faced by paralympic athletes with spinal cord injury.
For more info please see the link above.
The event is free, but space is limited. Register now to avoid disappointment.
Supported by Canadian Institutes for Health Research